Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 344 followers
Latest posts
Last updated about 15 hours ago
Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice
about 15 hours ago
Artelo Biosciences’ oral dual cannabinoid agonist showed weight loss comparable to the...
Beyond clinical endpoints: Rethinking ALS drug development through disease biology
about 17 hours ago
After decades of hard-won progress, ALS drug development is entering a new...
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
about 17 hours ago
New-look Novo is digging deeper into its metabolic roots with three new...
Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system
about 18 hours ago
The FDA has cleared Medtronic’s LigaSure RAS Maryland jaw vessel sealer-divider to...
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
about 18 hours ago
The FDA granted Aptitude its first 510(k) clearance for the next-generation Metrix...
Inside the growing world of biopharma prediction markets
about 20 hours ago
In this episode of “The Top Line,” we explore the growing space...
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
about 22 hours ago
After former Legend Biotech CEO Ying Huang, Ph.D., left the company suddenly...
Xenon pauses phase 3 depression trials after psychosis events
about 24 hours ago
The company has voluntarily stopped enrolling new patients in the studies in...
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
1 day ago
Bristol Myers Squibb has axed the degrader-antibody conjugate it bought from Orum...
Inflammation biotech Electra charges up with $350M from upsized IPO
1 day ago
Electra Therapeutics is the latest biotech to overshoot its own IPO expectations...
DPHARM: How to address the clinical trial enrollment crisis?
1 day ago
Clinical trials are facing an enrollment crisis. Around 80% of trials don’t...
Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
1 day ago
A new biotech has sprung out of stealth with a bold vision...